| Dai Wei Zhang, MD | |
|
9601 Townline Rd, Minocqua, WI 54548 | |
| (715) 358-1000 | |
| Not Available |
| Full Name | Dai Wei Zhang |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 36 Years |
| Location | 9601 Townline Rd, Minocqua, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871693143 | NPI | - | NPPES |
| 32641000 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 42167 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventist Health Simi Valley | Simi valley, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Simi Radiology And Imaging Medical Group | 6507845369 | 45 |
News Archive
The American Legislative Exchange Council (ALEC)—the nation's largest nonpartisan individual membership association of state legislators—congratulates Idaho State Representatives Jim Clark, Lynn Luker, and Raul Labrador for their successful sponsorship of HB 391, the Idaho Health Freedom Act, which was passed by the Idaho House of Representatives by a vote of 52 to 18 last week.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues finds that, following its launch and uptake, GlaxoSmithKline's angiogenesis inhibitor Votrient (formerly Armala) will garner sales of $640 million by 2018 and will take significant market share away from Pfizer's Sutent. In 2008, Sutent had accounted for 61 percent of sales in the angiogenesis inhibitor drug class.
Promedior, Inc., a leader in the development of novel therapeutics for the treatment of fibrotic diseases and tissue remodeling, announced today that the European Commission has granted Orphan Medicinal Product Designation to its lead drug candidate PRM-151 for use in the prevention of scarring post glaucoma filtration surgery.
Advances in our understanding of the development and persistence of Obsessive-Compulsive Disorder have the potential to improve treatment according to a new study by the University of Waterloo.
› Verified 1 days ago
| Entity Name | West Valley Radiology Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265486427 PECOS PAC ID: 1658266622 Enrollment ID: O20040308001429 |
News Archive
The American Legislative Exchange Council (ALEC)—the nation's largest nonpartisan individual membership association of state legislators—congratulates Idaho State Representatives Jim Clark, Lynn Luker, and Raul Labrador for their successful sponsorship of HB 391, the Idaho Health Freedom Act, which was passed by the Idaho House of Representatives by a vote of 52 to 18 last week.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues finds that, following its launch and uptake, GlaxoSmithKline's angiogenesis inhibitor Votrient (formerly Armala) will garner sales of $640 million by 2018 and will take significant market share away from Pfizer's Sutent. In 2008, Sutent had accounted for 61 percent of sales in the angiogenesis inhibitor drug class.
Promedior, Inc., a leader in the development of novel therapeutics for the treatment of fibrotic diseases and tissue remodeling, announced today that the European Commission has granted Orphan Medicinal Product Designation to its lead drug candidate PRM-151 for use in the prevention of scarring post glaucoma filtration surgery.
Advances in our understanding of the development and persistence of Obsessive-Compulsive Disorder have the potential to improve treatment according to a new study by the University of Waterloo.
› Verified 1 days ago
| Entity Name | Simi Radiology And Imaging Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730132275 PECOS PAC ID: 6507845369 Enrollment ID: O20040715000599 |
News Archive
The American Legislative Exchange Council (ALEC)—the nation's largest nonpartisan individual membership association of state legislators—congratulates Idaho State Representatives Jim Clark, Lynn Luker, and Raul Labrador for their successful sponsorship of HB 391, the Idaho Health Freedom Act, which was passed by the Idaho House of Representatives by a vote of 52 to 18 last week.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues finds that, following its launch and uptake, GlaxoSmithKline's angiogenesis inhibitor Votrient (formerly Armala) will garner sales of $640 million by 2018 and will take significant market share away from Pfizer's Sutent. In 2008, Sutent had accounted for 61 percent of sales in the angiogenesis inhibitor drug class.
Promedior, Inc., a leader in the development of novel therapeutics for the treatment of fibrotic diseases and tissue remodeling, announced today that the European Commission has granted Orphan Medicinal Product Designation to its lead drug candidate PRM-151 for use in the prevention of scarring post glaucoma filtration surgery.
Advances in our understanding of the development and persistence of Obsessive-Compulsive Disorder have the potential to improve treatment according to a new study by the University of Waterloo.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dai Wei Zhang, MD 1000 N Oak Ave, Marshfield, WI 54449-5777 Ph: () - | Dai Wei Zhang, MD 9601 Townline Rd, Minocqua, WI 54548 Ph: (715) 358-1000 |
News Archive
The American Legislative Exchange Council (ALEC)—the nation's largest nonpartisan individual membership association of state legislators—congratulates Idaho State Representatives Jim Clark, Lynn Luker, and Raul Labrador for their successful sponsorship of HB 391, the Idaho Health Freedom Act, which was passed by the Idaho House of Representatives by a vote of 52 to 18 last week.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues finds that, following its launch and uptake, GlaxoSmithKline's angiogenesis inhibitor Votrient (formerly Armala) will garner sales of $640 million by 2018 and will take significant market share away from Pfizer's Sutent. In 2008, Sutent had accounted for 61 percent of sales in the angiogenesis inhibitor drug class.
Promedior, Inc., a leader in the development of novel therapeutics for the treatment of fibrotic diseases and tissue remodeling, announced today that the European Commission has granted Orphan Medicinal Product Designation to its lead drug candidate PRM-151 for use in the prevention of scarring post glaucoma filtration surgery.
Advances in our understanding of the development and persistence of Obsessive-Compulsive Disorder have the potential to improve treatment according to a new study by the University of Waterloo.
› Verified 1 days ago
James E Tomic, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 9601 Townline Rd, Minocqua, WI 54548 Phone: 715-387-5511 | |
Dr. David Fay Lee, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 9601 Townline Rd, Minocqua, WI 54548 Phone: 715-358-1355 Fax: 715-358-1897 | |
Jeremiah J. Libby, DO Radiology Medicare: Accepting Medicare Assignments Practice Location: 9576 Highway 70, Minocqua, WI 54548 Phone: 715-358-1000 | |
Nicholas Bodmer, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 9576 Wi-70, Minocqua, WI 54548 Phone: 715-358-1275 | |
Baruch E Kahana, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 9601 Townline Rd, Minocqua, WI 54548 Phone: 715-358-1363 |